Negative regulation of HIV-1 transcription by a heterodimeric NF-κB1/p50 and C-terminally truncated STAT5 complex

Journal of Molecular Biology

Volumn 410, Issue 5, 2011, Pages 933-943

  Della Chiara, Giulia ^a   Crotti, Andrea ^a   Liboi, Elio ^b   Giacca, Mauro ^c   Poli, Guido ^a,d   Lusic, Marina ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

HIV 1; latency; LTR; p50 NF B; STAT5

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA POLYMERASE II; STAT5 PROTEIN; TRANSCRIPTION FACTOR RELA;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; ENZYME ACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

DELLA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79960380793     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.03.044     Document Type: Article

References (33)

1. Folkers G.K.; and Fauci A.S. Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal JAMA 304 2010 350 351
2. Richman D.D.; Margolis D.M.; Delaney M.; Greene W.C.; Hazuda D.; and Pomerantz R.J. The challenge of finding a cure for HIV infection Science 323 2009 1304 1307
3. Colin L.; and Van Lint C. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies Retrovirology 6 2009 111
4. Berkhout B.; and Jeang K.T. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat J. Virol. 66 1992 139 149
5. + T lymphocytes J. Leukocyte Biol. 87 2010 575 588
6. Chan J.K.; and Greene W.C. NF-kappaB/Rel: agonist and antagonist roles in HIV-1 latency Curr. Opin. HIV AIDS 6 2011 12 18
7. Williams S.A.; and Greene W.C. Host factors regulating post-integration latency of HIV Trends Microbiol. 13 2005 137 139 (Pubitemid 40463312)
8. Shuai K.; and Liu B. Regulation of JAK-STAT signalling in the immune system Nat. Rev.; Immunol. 3 2003 900 911 (Pubitemid 37411719)
9. Selliah N.; Zhang M.; DeSimone D.; Kim H.; Brunner M.; and Ittenbach R.F. The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells Virology 344 2006 283 291 (Pubitemid 43049616)
10. Bovolenta C.; Camorali L.; Lorini A.L.; Ghezzi S.; Vicenzi E.; Lazzarin A.; and Poli G. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection Blood 94 1999 4202 4209
11. Crotti A.; Lusic M.; Lupo R.; Lievens P.M.; Liboi E.; and Della Chiara G. Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression Blood 109 2007 5380 5389 (Pubitemid 46890560)
12. Azam M.; Lee C.; Strehlow I.; and Schindler C. Functionally distinct isoforms of STAT5 are generated by protein processing Immunity 6 1997 691 701 (Pubitemid 27305732)
13. Wang D.; Stravopodis D.; Teglund S.; Kitazawa J.; and Ihle J.N. Naturally occurring dominant negative variants of Stat5 Mol. Cell. Biol. 16 1996 6141 6148 (Pubitemid 26360974)
14. Kimura A.; Naka T.; Muta T.; Takeuchi O.; Akira S.; Kawase I.; and Kishimoto T. Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT Proc. Natl Acad. Sci. USA 102 2005 17089 17094 (Pubitemid 41692688)
15. Nabel G.; and Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells Nature 326 1987 711 713 (Pubitemid 17059793)
16. Kilareski E.M.; Shah S.; Nonnemacher M.R.; and Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage Retrovirology 6 2009 118
17. Williams S.A.; Chen L.F.; Kwon H.; Ruiz-Jarabo C.M.; Verdin E.; and Greene W.C. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation EMBO J. 25 2006 139 149 (Pubitemid 43077303)
18. Crotti A.; Chiara G.D.; Ghezzi S.; Lupo R.; Jeeninga R.E.; and Liboi E. Heterogeneity of signal transducer and activator of transcription binding sites in the long-terminal repeats of distinct HIV-1 subtypes Open Virol. J. 1 2007 26 32
19. Ariyoshi K.; Nosaka T.; Yamada K.; Onishi M.; Oka Y.; Miyajima A.; and Kitamura T. Constitutive activation of STAT5 by a point mutation in the SH2 domain J. Biol. Chem. 275 2000 24407 24413 (Pubitemid 30626531)
20. Lewin S.R.; Lambert P.; Deacon N.J.; Mills J.; and Crowe S.M. Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages J. Virol. 71 1997 2114 2119 (Pubitemid 27078590)
21. Porta C.; Rimoldi M.; Raes G.; Brys L.; Ghezzi P.; and Di Liberto D. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB Proc. Natl Acad. Sci. USA 106 2009 14978 14983
22. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
23. Cruz M.T.; Duarte C.B.; Goncalo M.; Figueiredo A.; Carvalho A.P.; and Lopes M.C. Granulocyte-macrophage colony-stimulating factor activates the transcription of nuclear factor kappa B and induces the expression of nitric oxide synthase in a skin dendritic cell line Immunol. Cell Biol. 79 2001 590 596 (Pubitemid 33070447)
24. Xu J.; Lucas R.; Schuchmann M.; Kuhnle S.; Meergans T.; and Barreiros A.P. GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro J. Immunol. 171 2003 938 947 (Pubitemid 36871408)
25. Karin M.; Cao Y.; Greten F.R.; and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit Nat. Rev.; Cancer 2 2002 301 310 (Pubitemid 37328783)
26. Oakes J.W.; Bagasra O.; Duan L.; and Pomerantz R.J. Association of alterations in NF-kappa B moieties with HIV type 1 proviral latency in certain monocytic cells AIDS Res. Hum. Retroviruses 10 1994 1213 1219 (Pubitemid 24349697)
27. Lusic M.; Marcello A.; Cereseto A.; and Giacca M. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter EMBO J. 22 2003 6550 6561 (Pubitemid 38009602)
28. Ghosh S.; May M.J.; and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16 1998 225 260 (Pubitemid 28183365)
29. Cao S.; Zhang X.; Edwards J.P.; and Mosser D.M. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages J. Biol. Chem. 281 2006 26041 26050 (Pubitemid 44401810)
30. Fujita T.; Nolan G.P.; Liou H.C.; Scott M.L.; and Baltimore D. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers Genes Dev. 7 1993 1354 1363 (Pubitemid 23210884)
31. Watanabe N.; Iwamura T.; Shinoda T.; and Fujita T. Regulation of NFκB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation EMBO J. 16 1997 3609 3620 (Pubitemid 27250054)
32. Zhong H.; May M.J.; Jimi E.; and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 Mol. Cell 9 2002 625 636 (Pubitemid 34273792)
33. Alfano M.; Vallanti G.; Biswas P.; Bovolenta C.; Vicenzi E.; and Mantelli B. The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells J. Immunol. 166 2001 1863 1870 (Pubitemid 32114672)